← Back to headlines
Apogee Therapeutics Stock Rises on $10.9 Billion Merger with AbbVie
Apogee Therapeutics (APGE) shares reached a fresh high following the announcement of a $10.9 billion merger with AbbVie, signaling a major acquisition in the pharmaceutical industry.
23 Jun, 01:53 — 23 Jun, 01:53
Sources
Showing 1 of 1 sources
